News

Key Takeaways A Chinese-developed GLP-1 drug is as effective as Ozempic or Zepbound, clinical trial saysEcnoglutide helped patients lose more than 15% of their body weightNearly 93% of clinical trial ...
In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...